The Janus Face of Insulin in Brain

Ana I Duarte , Emanuel Candeias, Sónia C Correia, Renato X. Santos, Cristina Carvalho, Susana Cardoso, Ana I Plácido, Maria Sancha Santos, Catarina R Oliveira, Paula Isabel da Silva Moreira

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Important studies recently reported that insulin exerts a neuroprotective effect and that decreased brain insulin levels and/or insulin and its receptors (IR)‐mediated signaling are linked to several age‐related neurodegenerative diseases. These findings were further potentiated by the recent hypothesis that insulin may constitute the potential missing link between diabetes and Alzheimer disease (AD) in the central nervous system (CNS), resulting in AD being called “type 3 diabetes.” In this regard, insulin could be a very promising therapy against diabetes‐ and age‐related neurodegenerative diseases. However, some studies (including longevity ones) have given controversial results on the beneficial effects of CNS insulin/IR activity. Herewith, the authors aim to critically analyze the pros and cons of insulin in the CNS, especially regarding age‐ and diabetes‐related neurodegeneration.
Original languageEnglish
Title of host publicationMetabolic Syndrome and Neurological Disorders
EditorsTahira Farooqui, Akhlaq A. Farooqui
PublisherJohn Wiley & Sons Ltd.
Chapter5
Pages85-113
Number of pages29
ISBN (Electronic)9781118395318
ISBN (Print)9781118395271
DOIs
Publication statusPublished - 15 Nov 2013

Fingerprint

Insulin
Brain
Central Nervous System
Insulin Receptor
Neurodegenerative Diseases
Alzheimer Disease
Neuroprotective Agents
Therapeutics

Keywords

  • Alzheimer disease (AD)
  • brain
  • central nervous system (CNS)
  • diabetes
  • insulin
  • neurodegeneration

Cite this

Duarte , A. I., Candeias, E., Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., ... da Silva Moreira, P. I. (2013). The Janus Face of Insulin in Brain. In T. Farooqui, & A. A. Farooqui (Eds.), Metabolic Syndrome and Neurological Disorders (pp. 85-113). John Wiley & Sons Ltd.. https://doi.org/10.1002/9781118395318.ch5

The Janus Face of Insulin in Brain. / Duarte , Ana I; Candeias, Emanuel ; Correia, Sónia C; Santos, Renato X.; Carvalho, Cristina; Cardoso, Susana; Plácido, Ana I; Santos, Maria Sancha; Oliveira, Catarina R; da Silva Moreira, Paula Isabel.

Metabolic Syndrome and Neurological Disorders. ed. / Tahira Farooqui; Akhlaq A. Farooqui. John Wiley & Sons Ltd., 2013. p. 85-113.

Research output: Chapter in Book/Report/Conference proceedingChapter

Duarte , AI, Candeias, E, Correia, SC, Santos, RX, Carvalho, C, Cardoso, S, Plácido, AI, Santos, MS, Oliveira, CR & da Silva Moreira, PI 2013, The Janus Face of Insulin in Brain. in T Farooqui & AA Farooqui (eds), Metabolic Syndrome and Neurological Disorders. John Wiley & Sons Ltd., pp. 85-113. https://doi.org/10.1002/9781118395318.ch5
Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S et al. The Janus Face of Insulin in Brain. In Farooqui T, Farooqui AA, editors, Metabolic Syndrome and Neurological Disorders. John Wiley & Sons Ltd. 2013. p. 85-113 https://doi.org/10.1002/9781118395318.ch5
Duarte , Ana I ; Candeias, Emanuel ; Correia, Sónia C ; Santos, Renato X. ; Carvalho, Cristina ; Cardoso, Susana ; Plácido, Ana I ; Santos, Maria Sancha ; Oliveira, Catarina R ; da Silva Moreira, Paula Isabel. / The Janus Face of Insulin in Brain. Metabolic Syndrome and Neurological Disorders. editor / Tahira Farooqui ; Akhlaq A. Farooqui. John Wiley & Sons Ltd., 2013. pp. 85-113
@inbook{a2b762c7317e4850934b63374fcd530e,
title = "The Janus Face of Insulin in Brain",
abstract = "Important studies recently reported that insulin exerts a neuroprotective effect and that decreased brain insulin levels and/or insulin and its receptors (IR)‐mediated signaling are linked to several age‐related neurodegenerative diseases. These findings were further potentiated by the recent hypothesis that insulin may constitute the potential missing link between diabetes and Alzheimer disease (AD) in the central nervous system (CNS), resulting in AD being called “type 3 diabetes.” In this regard, insulin could be a very promising therapy against diabetes‐ and age‐related neurodegenerative diseases. However, some studies (including longevity ones) have given controversial results on the beneficial effects of CNS insulin/IR activity. Herewith, the authors aim to critically analyze the pros and cons of insulin in the CNS, especially regarding age‐ and diabetes‐related neurodegeneration.",
keywords = "Alzheimer disease (AD), brain, central nervous system (CNS), diabetes, insulin, neurodegeneration",
author = "Duarte, {Ana I} and Emanuel Candeias and Correia, {S{\'o}nia C} and Santos, {Renato X.} and Cristina Carvalho and Susana Cardoso and Pl{\'a}cido, {Ana I} and Santos, {Maria Sancha} and Oliveira, {Catarina R} and {da Silva Moreira}, {Paula Isabel}",
year = "2013",
month = "11",
day = "15",
doi = "10.1002/9781118395318.ch5",
language = "English",
isbn = "9781118395271",
pages = "85--113",
editor = "Tahira Farooqui and Farooqui, {Akhlaq A.}",
booktitle = "Metabolic Syndrome and Neurological Disorders",
publisher = "John Wiley & Sons Ltd.",
address = "United Kingdom",

}

TY - CHAP

T1 - The Janus Face of Insulin in Brain

AU - Duarte , Ana I

AU - Candeias, Emanuel

AU - Correia, Sónia C

AU - Santos, Renato X.

AU - Carvalho, Cristina

AU - Cardoso, Susana

AU - Plácido, Ana I

AU - Santos, Maria Sancha

AU - Oliveira, Catarina R

AU - da Silva Moreira, Paula Isabel

PY - 2013/11/15

Y1 - 2013/11/15

N2 - Important studies recently reported that insulin exerts a neuroprotective effect and that decreased brain insulin levels and/or insulin and its receptors (IR)‐mediated signaling are linked to several age‐related neurodegenerative diseases. These findings were further potentiated by the recent hypothesis that insulin may constitute the potential missing link between diabetes and Alzheimer disease (AD) in the central nervous system (CNS), resulting in AD being called “type 3 diabetes.” In this regard, insulin could be a very promising therapy against diabetes‐ and age‐related neurodegenerative diseases. However, some studies (including longevity ones) have given controversial results on the beneficial effects of CNS insulin/IR activity. Herewith, the authors aim to critically analyze the pros and cons of insulin in the CNS, especially regarding age‐ and diabetes‐related neurodegeneration.

AB - Important studies recently reported that insulin exerts a neuroprotective effect and that decreased brain insulin levels and/or insulin and its receptors (IR)‐mediated signaling are linked to several age‐related neurodegenerative diseases. These findings were further potentiated by the recent hypothesis that insulin may constitute the potential missing link between diabetes and Alzheimer disease (AD) in the central nervous system (CNS), resulting in AD being called “type 3 diabetes.” In this regard, insulin could be a very promising therapy against diabetes‐ and age‐related neurodegenerative diseases. However, some studies (including longevity ones) have given controversial results on the beneficial effects of CNS insulin/IR activity. Herewith, the authors aim to critically analyze the pros and cons of insulin in the CNS, especially regarding age‐ and diabetes‐related neurodegeneration.

KW - Alzheimer disease (AD)

KW - brain

KW - central nervous system (CNS)

KW - diabetes

KW - insulin

KW - neurodegeneration

U2 - 10.1002/9781118395318.ch5

DO - 10.1002/9781118395318.ch5

M3 - Chapter

SN - 9781118395271

SP - 85

EP - 113

BT - Metabolic Syndrome and Neurological Disorders

A2 - Farooqui, Tahira

A2 - Farooqui, Akhlaq A.

PB - John Wiley & Sons Ltd.

ER -